Figure 1.
Figure 1. PRMT5 is required for GC formation and affinity maturation. (A) Immunohistochemistry of paraffin-embedded splenic tissue from Cγ1-Cre−/− Prmt5fl/fl and Cγ1-Cre+/− Prmt5fl/fl mice (n = 7 per group) immunized with SRBCs for 10 days. (B) Quantification of PNA+ clusters from panel A. (C) Representative flow cytometry plot showing percentage of GC B cells (GL7+ FAS+ or CD38dim FAS+) gated on live B220+ splenocytes in Cγ1-Cre−/− Prmt5fl/fl and Cγ1-Cre+/− Prmt5fl/fl mice (n = 7 per group) immunized with SRBC as described in panel A. (D) Titers of low-affinity NP-specific immunoglobulin were measured using NP26-BSA in the serum of Cγ1-Cre−/− Prmt5fl/fl and Cγ1-Cre+/− Prmt5fl/fl mice (n = 6 per group) immunized with NP-CGG for 8 days. (E) Ratio of high- to low-affinity NP-specific immunoglobulin detected with NP4-BSA and NP26-BSA, respectively, in NP-CGG immunized Cγ1-Cre−/− Prmt5fl/fl and Cγ1-Cre+/− Prmt5fl/fl mice described in panel D.

PRMT5 is required for GC formation and affinity maturation. (A) Immunohistochemistry of paraffin-embedded splenic tissue from Cγ1-Cre−/−Prmt5fl/fl and Cγ1-Cre+/−Prmt5fl/fl mice (n = 7 per group) immunized with SRBCs for 10 days. (B) Quantification of PNA+ clusters from panel A. (C) Representative flow cytometry plot showing percentage of GC B cells (GL7+ FAS+ or CD38dim FAS+) gated on live B220+ splenocytes in Cγ1-Cre−/−Prmt5fl/fl and Cγ1-Cre+/−Prmt5fl/fl mice (n = 7 per group) immunized with SRBC as described in panel A. (D) Titers of low-affinity NP-specific immunoglobulin were measured using NP26-BSA in the serum of Cγ1-Cre−/−Prmt5fl/fl and Cγ1-Cre+/−Prmt5fl/fl mice (n = 6 per group) immunized with NP-CGG for 8 days. (E) Ratio of high- to low-affinity NP-specific immunoglobulin detected with NP4-BSA and NP26-BSA, respectively, in NP-CGG immunized Cγ1-Cre−/−Prmt5fl/fl and Cγ1-Cre+/−Prmt5fl/fl mice described in panel D.

Close Modal

or Create an Account

Close Modal
Close Modal